HELP ADVANCE ALZHEIMER’S DISEASE RESEARCH
Learn more about participating in an ASCENT clinical trial.
The ASCENT clinical trials are seeking participants aged 55 to 85 with mild Alzheimer’s disease to understand the safety of an investigational* drug called PRX012.
You or a Loved One May Qualify if You or They:
• Are 55 to 85 years old
• Have a confirmed or suspected diagnosis of mild Alzheimer’s disease or mild cognitive impairment due to Alzheimer’s disease
• Have gradual and progressive change in memory function for at least 6 months
• Are willing and able to complete brain imaging (MRI and PET scans)
There are additional study requirements to participate. A study representative will discuss them with you.